Larimar Therapeutics Inc’s recently made public that its Director Flynn James E acquired Company’s shares for reported $37.5 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Larimar Therapeutics
In a filing, Larimar Therapeutics Inc revealed its Director Flynn James E acquired Company’s shares for reported $37.5 million on
Larimar Therapeutics Inc’s recent filing unveils that its Director Flynn James E acquired Company’s shares for reported $37.5 million on
Larimar Therapeutics Inc’s recent filing unveils that its Director Flynn James E acquired Company’s shares for reported $37.5 million on